Sec. 0.5. (a) An opioid treatment program shall not operate in Indiana unless the opioid treatment program meets the following conditions:

(1) Is specifically approved and the opioid treatment facility is certified by the division.

(2) Is in compliance with state and federal law.

(3) Provides treatment for opioid addiction using a drug approved by the federal Food and Drug Administration for the treatment of opioid addiction, including:

(A) opioid maintenance;

(B) detoxification;

(C) overdose reversal;

(D) relapse prevention; and

(E) long acting, nonaddictive medication assisted treatment medications.

(4) Beginning July 1, 2017, is:

(A) enrolled:

(i) as a Medicaid provider under IC 12-15; and

(ii) as a healthy Indiana plan provider under IC 12-15-44.2; or

(B) enrolled as an ordering, prescribing, or referring provider in accordance with Section 6401 of the federal Patient Protection and Affordable Care Act (P.L. 111-148), as amended by the federal Health Care and Education Reconciliation Act of 2010 (P.L. 111-152) and maintains a memorandum of understanding with a community mental health center for the purpose of ordering, prescribing, or referring treatments covered by Medicaid and the healthy Indiana plan.

     (b) Separate specific approval and certification under this chapter is required for each location at which an opioid treatment program is operated. If an opioid treatment program moves the opioid treatment program’s facility to another location, the opioid treatment program’s certification does not apply to the new location and certification for the new location under this chapter is required.

     (c) Each opioid treatment program that is enrolled as an ordering, prescribing, or referring provider shall report to the office on an annual basis the services provided to Indiana Medicaid patients. The report must include the following:

(1) The number of Medicaid patients seen by the ordering, prescribing, or referring provider.

(2) The services received by the provider’s Medicaid patients, including any drugs prescribed.

(3) The number of Medicaid patients referred to other providers.

(4) Any other provider types to which the Medicaid patients were referred.

As added by P.L.116-2008, SEC.2. Amended by P.L.1-2009, SEC.108; P.L.8-2016, SEC.2.